323 related articles for article (PubMed ID: 27807282)
1. Genetic interrogation of circulating multiple myeloma cells at single-cell resolution.
Lohr JG; Kim S; Gould J; Knoechel B; Drier Y; Cotton MJ; Gray D; Birrer N; Wong B; Ha G; Zhang CZ; Guo G; Meyerson M; Yee AJ; Boehm JS; Raje N; Golub TR
Sci Transl Med; 2016 Nov; 8(363):363ra147. PubMed ID: 27807282
[TBL] [Abstract][Full Text] [Related]
2. Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones.
Ndacayisaba LJ; Rappard KE; Shishido SN; Ruiz Velasco C; Matsumoto N; Navarez R; Tang G; Lin P; Setayesh SM; Naghdloo A; Hsu CJ; Maney C; Symer D; Bethel K; Kelly K; Merchant A; Orlowski R; Hicks J; Mason J; Manasanch EE; Kuhn P
Curr Oncol; 2022 Apr; 29(5):2954-2972. PubMed ID: 35621632
[TBL] [Abstract][Full Text] [Related]
3. MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology.
Dutta AK; Alberge JB; Lightbody ED; Boehner CJ; Dunford A; Sklavenitis-Pistofidis R; Mouhieddine TH; Cowan AN; Su NK; Horowitz EM; Barr H; Hevenor L; Beckwith JB; Perry J; Cao A; Lin Z; Kuhr FK; Mastro RGD; Nadeem O; Greipp PT; Stewart C; Auclair D; Getz G; Ghobrial IM
Cancer Discov; 2023 Feb; 13(2):348-363. PubMed ID: 36477267
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma.
Garcés JJ; Bretones G; Burgos L; Valdes-Mas R; Puig N; Cedena MT; Alignani D; Rodriguez I; Puente DÁ; Álvarez MG; Goicoechea I; Rodriguez S; Calasanz MJ; Agirre X; Flores-Montero J; Sanoja-Flores L; Rodriguez-Otero P; Rios R; Martinez-Lopez J; Millacoy P; Palomera L; Del Orbe R; Pérez-Montaña A; El Omri H; Prosper F; Mateos MV; Rosiñol L; Blade J; Lahuerta JJ; Orfao A; Lopez-Otin C; San Miguel JF; Paiva B;
Leukemia; 2020 Nov; 34(11):3007-3018. PubMed ID: 32475991
[TBL] [Abstract][Full Text] [Related]
5. Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients.
Cho WJ; Oliveira DS; Najy AJ; Mainetti LE; Aoun HD; Cher ML; Heath E; Kim HR; Bonfil RD
J Transl Med; 2016 Mar; 14():72. PubMed ID: 26975354
[TBL] [Abstract][Full Text] [Related]
6. The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma.
Mishima Y; Paiva B; Shi J; Park J; Manier S; Takagi S; Massoud M; Perilla-Glen A; Aljawai Y; Huynh D; Roccaro AM; Sacco A; Capelletti M; Detappe A; Alignani D; Anderson KC; Munshi NC; Prosper F; Lohr JG; Ha G; Freeman SS; Van Allen EM; Adalsteinsson VA; Michor F; San Miguel JF; Ghobrial IM
Cell Rep; 2017 Apr; 19(1):218-224. PubMed ID: 28380360
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow angiogenesis and circulating plasma cells in multiple myeloma.
Kumar S; Witzig TE; Greipp PR; Rajkumar SV
Br J Haematol; 2003 Jul; 122(2):272-4. PubMed ID: 12846897
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination.
Garcés JJ; Simicek M; Vicari M; Brozova L; Burgos L; Bezdekova R; Alignani D; Calasanz MJ; Growkova K; Goicoechea I; Agirre X; Pour L; Prosper F; Rios R; Martinez-Lopez J; Millacoy P; Palomera L; Del Orbe R; Perez-Montaña A; Garate S; Blanco L; Lasa M; Maiso P; Flores-Montero J; Sanoja-Flores L; Chyra Z; Vdovin A; Sevcikova T; Jelinek T; Botta C; El Omri H; Keats J; Orfao A; Hajek R; San-Miguel JF; Paiva B
Leukemia; 2020 Feb; 34(2):589-603. PubMed ID: 31595039
[TBL] [Abstract][Full Text] [Related]
9. Ultradeep, targeted sequencing reveals distinct mutations in blood compared to matched bone marrow among patients with multiple myeloma.
Coffey DG; Wu QV; Towlerton AMH; Ornelas S; Morales AJ; Xu Y; Green DJ; Warren EH
Blood Cancer J; 2019 Sep; 9(10):77. PubMed ID: 31570697
[No Abstract] [Full Text] [Related]
10. Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disorders.
Foulk B; Schaffer M; Gross S; Rao C; Smirnov D; Connelly MC; Chaturvedi S; Reddy M; Brittingham G; Mata M; Repollet M; Rojas C; Auclair D; DeRome M; ; Weiss B; Sasser AK
Br J Haematol; 2018 Jan; 180(1):71-81. PubMed ID: 29105742
[TBL] [Abstract][Full Text] [Related]
11. Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile.
Paiva B; Paino T; Sayagues JM; Garayoa M; San-Segundo L; Martín M; Mota I; Sanchez ML; Bárcena P; Aires-Mejia I; Corchete L; Jimenez C; Garcia-Sanz R; Gutierrez NC; Ocio EM; Mateos MV; Vidriales MB; Orfao A; San Miguel JF
Blood; 2013 Nov; 122(22):3591-8. PubMed ID: 24072855
[TBL] [Abstract][Full Text] [Related]
12. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
Riethdorf S; Pantel K
Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
[TBL] [Abstract][Full Text] [Related]
13. DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow Microenvironment.
Hewett DR; Vandyke K; Lawrence DM; Friend N; Noll JE; Geoghegan JM; Croucher PI; Zannettino ACW
Neoplasia; 2017 Dec; 19(12):972-981. PubMed ID: 29091798
[TBL] [Abstract][Full Text] [Related]
14. Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.
Rasche L; Chavan SS; Stephens OW; Patel PH; Tytarenko R; Ashby C; Bauer M; Stein C; Deshpande S; Wardell C; Buzder T; Molnar G; Zangari M; van Rhee F; Thanendrarajan S; Schinke C; Epstein J; Davies FE; Walker BA; Meissner T; Barlogie B; Morgan GJ; Weinhold N
Nat Commun; 2017 Aug; 8(1):268. PubMed ID: 28814763
[TBL] [Abstract][Full Text] [Related]
15. Liquid Biopsies - the Clinics and the Molecules.
Kubaczková V; Sedlarikova L; Bollová B; Sandecká V; Stork M; Pour L; Sevcikova S
Klin Onkol; 2017; 30(Supplementum2):13-20. PubMed ID: 28903565
[TBL] [Abstract][Full Text] [Related]
16. Liquid Biopsies as Non-Invasive Tools for Mutation Profiling in Multiple Myeloma: Application Potential, Challenges, and Opportunities.
Heestermans R; Schots R; De Becker A; Van Riet I
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791247
[TBL] [Abstract][Full Text] [Related]
17. [Detection of circulating and bone marrow myeloma cells in patients with multiple myeloma and its clinical significance].
Jiang YQ; Li JY; Wu YJ; Yang H; Shen YF; Chen LJ; Xu W; Qian SX; Wu HX; Lu H; Shen RL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):908-12. PubMed ID: 17096887
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.
Gröbe A; Blessmann M; Hanken H; Friedrich RE; Schön G; Wikner J; Effenberger KE; Kluwe L; Heiland M; Pantel K; Riethdorf S
Clin Cancer Res; 2014 Jan; 20(2):425-33. PubMed ID: 24218516
[TBL] [Abstract][Full Text] [Related]
19. KRAS mutation analysis of single circulating tumor cells from patients with metastatic colorectal cancer.
Kondo Y; Hayashi K; Kawakami K; Miwa Y; Hayashi H; Yamamoto M
BMC Cancer; 2017 May; 17(1):311. PubMed ID: 28468669
[TBL] [Abstract][Full Text] [Related]
20. Single-Cell Analysis of Circulating Tumor Cells as a Window into Tumor Heterogeneity.
Miyamoto DT; Ting DT; Toner M; Maheswaran S; Haber DA
Cold Spring Harb Symp Quant Biol; 2016; 81():269-274. PubMed ID: 28389596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
